Sign in
4/A

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-22-040302

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
VANLENT ANNE Director 2022-06-23 Grant or award · Nonstatutory Stock Option (right to buy) +20,000 20,000 D
Loading xslF345X03/doc4a.xml…